Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Mindeudesivir hydrobromide | 2779498-79-0 | 98.16% | C24H31DBrN5O7 | 50 MG
SDP

Catalog No. 5000356236
Encompass_Preferred

Mindeudesivir hydrobromide is a deuterated version of Remdesivir, a highly orally active nucleoside antiviral effective against SARS-CoV-2 and respiratory syncytial virus (RSV). It maintains the antiviral activity of Remdesivir against COVID-19 and is the first domestically produced deuterium targeting COVID-19. This product is for research use only.

  • Highly orally active nucleoside antiviral
  • Effective against SARS-CoV-2 and respiratory syncytial virus (RSV)
  • Maintains antiviral activity against COVID-19
  • First domestically produced deuterium targeting COVID-19
  • For research use only

Catalog No. 50-003-56236 Supplier Medchemexpress LLC Supplier No. HY145119AS50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Mindeudesivir hydrobromide is a deuterated version of Remdesivir, a highly orally active nucleoside antiviral effective against SARS-CoV-2 and respiratory syncytial virus (RSV). It maintains the antiviral activity of Remdesivir against COVID-19 and is the first domestically produced deuterium targeting COVID-19. This product is for research use only.

  • Highly orally active nucleoside antiviral
  • Effective against SARS-CoV-2 and respiratory syncytial virus (RSV)
  • Maintains antiviral activity against COVID-19
  • First domestically produced deuterium targeting COVID-19
  • For research use only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.